These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1. Uemura M; Fa'ak F; Haymaker C; McQuail N; Sirmans E; Hudgens CW; Barbara L; Bernatchez C; Curry JL; Hwu P; Tetzlaff MT; Diab A J Immunother Cancer; 2017; 5():7. PubMed ID: 28116090 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer. Miura T; Yoshizawa T; Hirai H; Seino H; Morohashi S; Wu Y; Wakiya T; Kimura N; Kudo D; Ishido K; Toyoki Y; Kijima H; Hakamada K Anticancer Res; 2017 Jan; 37(1):183-190. PubMed ID: 28011489 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status. Chung YR; Kim HJ; Jang MH; Park SY Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma. Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657 [TBL] [Abstract][Full Text] [Related]
11. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer. Wang K; Shen T; Siegal GP; Wei S Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast. Xu Y; Lan S; Zheng Q Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349 [TBL] [Abstract][Full Text] [Related]
13. Erratum to epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers. Ann Transl Med; 2017 Sep; 5(18):381. PubMed ID: 29057241 [TBL] [Abstract][Full Text] [Related]
14. Erratum: Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer [Corrigendum]. Pharmgenomics Pers Med; 2023; 16():1149-1150. PubMed ID: 38170144 [TBL] [Abstract][Full Text] [Related]
15. Erratum: Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology. Frontiers Production Office Front Immunol; 2019; 10():1868. PubMed ID: 31447856 [TBL] [Abstract][Full Text] [Related]
16. Triple negative breast cancer - prognostic role of immune-related factors: a systematic review. Stovgaard ES; Nielsen D; Hogdall E; Balslev E Acta Oncol; 2018 Jan; 57(1):74-82. PubMed ID: 29168430 [TBL] [Abstract][Full Text] [Related]
17. Erratum: Mismatched intratumoral distribution of [18F] fluorodeoxyglucose and 3'-deoxy-3'-[18F] fluorothymidine in patients with lung cancer. Wang X; He Y; Zhou W; Bai X; Wu Y; Wang X; Li XF Oncol Lett; 2018 Jul; 16(1):1367. PubMed ID: 30061957 [TBL] [Abstract][Full Text] [Related]
19. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400 [TBL] [Abstract][Full Text] [Related]
20. In situ localization of tumor cells associated with the epithelial-mesenchymal transition marker Snail and the prognostic impact of lymphocytes in the tumor microenvironment in invasive ductal breast cancer. Alkatout I; Hübner F; Wenners A; Hedderich J; Wiedermann M; Sánchez C; Röcken C; Mathiak M; Maass N; Klapper W Exp Mol Pathol; 2017 Apr; 102(2):268-275. PubMed ID: 28232080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]